DOCSLIB.ORG

Konjac Glucomannan Polysaccharide and Inulin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Konjac Glucomannan Polysaccharide and Inulin BioMedicine Volume 11 Issue 3 Article 4 2021 Konjac glucomannan polysaccharide and inulin oligosaccharide ameliorate dextran sodium sulfate-induced colitis and alterations in fecal microbiota and short-chain fatty acids in C57BL/6J mice Follow this and additional works at: https://www.biomedicinej.com/biomedicine Part of the Life Sciences Commons, and the Medical Sciences Commons This work is licensed under a Creative Commons Attribution 4.0 License. Recommended Citation Changchien, Chih-Hsuan; Wang, Cheng-Hsin; and Chen, Hsiao-ling (2021) "Konjac glucomannan polysaccharide and inulin oligosaccharide ameliorate dextran sodium sulfate-induced colitis and alterations in fecal microbiota and short-chain fatty acids in C57BL/6J mice," BioMedicine: Vol. 11 : Iss. 3 , Article 4. DOI: 10.37796/2211-8039.1191 This Original Articles is brought to you for free and open access by BioMedicine. It has been accepted for inclusion in BioMedicine by an authorized editor of BioMedicine. Konjac glucomannan polysaccharide and inulin oligosaccharide ameliorate dextran sodium sulfate-induced colitis and alterations in fecal ORIGINAL ARTICLE microbiota and short-chain fatty acids in C57BL/6J mice Chih-Hsuan Changchien 1,2, Cheng-Hsin Wang 3, Hsiao-Ling Chen 4,5,* 1 Department of Medical Laboratory Science and Biotechnology, Asia University, Taiwan 2 Department of Plastic and Reconstructive Surgery, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Taiwan 3 Department of Food and Nutrition, Providence University, Taiwan 4 Department of Food, Nutrition and Health Biotechnology, Asia University, Taiwan 5 Department of Medical Research, China Medical University Hospital, China Medical University, Taiwan Abstract Background: Konjac glucomannan polysaccharide (KGM), inulin oligosaccharide (inulin) and their mixture has been shown to modulate the gut-associated lymphoid tissue immunity. Aims: The present study was mainly to determine effects of a low-level (2% w/w) KGM and inulin and their com- bination on dextran sodium sulfate (DSS)-induced colitis. We also determine the potential mechanisms mediating these effects of dietary fibers. Methods: C57BL/6J mice (6 weeks of age, eight per group) were randomly assigned to consume one of the following diets: control (DSS group) or control diet supplemented with 2% (w/w) of KGM (KGM group), 2% (w/w) of inulin oligosaccharide (inulin group) or KGMþInulin (1%, w/w each (KþI group)) for 29 days, combined with the DSS drinking water (2% w/v) treatment on days 21-26. Another group served as vehicle was fed the control diet and given regular drinking water throughout the study. Fresh feces were collected on days 26-29. Mice were killed on day 30 after fasting. Segments of distal colon were processed for histological procedure. The remaining colonic tissues were pro- cessed to determine the colonic gene expressions of cytokines, tight junction proteins and antioxidant enzymes. Results: The present study indicated that DSS resulted in colonic dysplasia, severe leukocyte infiltration and enhanced gene expressions of pro-inflammatory cytokines. All fiber treatments ameliorated these indices of colitis. DSS treatment reduced the colonic gene expressions of tight junction proteins and antioxidant enzymes, which were ameliorated or normalized with fiber supplementation. In addition, all fiber treatments prevented the DSS-induced alterations in the fecal microbiota and short-chain acid levels. Conclusion: Supplementation of low-level, 2% (w/w), of KGM polysaccharide, inulin oligosaccharide and K þ I reduced the DSS-induced colitis and mucosal barrier dysfunction, which was likely to be mediated by the prebiotic effects. Keywords: Colitis, Dextran sulfate sodium, Konjac glucomannan, Inulin, Microbiota, Mucosal barrier Introduction incidence and prevalence of IBD were the highest in western countries [2]. The reported annual he ulcerative colitis is an inflammatory incidence of ulcerative colitis was 24.3 and 19.2 T bowel disease (IBD) that occurs in the colon per 100,000 person-years in Europe and North [1]. Epidemiological studies found that the America, respectively [2]. The incidence is still Received 7 January 2021; revised 13 February 2021; accepted 17 February 2021. Available online 1 September, 2021. * Corresponding author at: Department of Food, Nutrition and Health Biotechnology, Asia University, No. 500, Lioufeng Rd., Taichung, Taiwan. Fax: þ886 4 23321215. E-mail address: [email protected] (H.-L. Chen). https://doi.org/10.37796/2211-8039.1191 2211-1191/Published by China Medical University 2021. © the Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 24 C.-H. CHANGCHIEN ET AL BioMedicine DIETARY FIBER AMELIORATES COLITIS-ASSOCIATED COLONIC DYSFUNCTION 2021;11(3):23e30 ORIGINAL ARTICLE arising in low-incidence areas such as Asia and microbial fermentation products short-chain fatty developing countries [2]. The pathogenesis of IBD acids and stimulate the growth of bifidobacteria and is multifactorial, involving mucosal barrier de- lactobacilli in animal/human studies [14,16-18]. fects, dysregulated immune responses, genetic KGM and inulin modulate the colonic antioxidant system and increased the antioxidant defense predisposition and environmental factors [3]. against the oxidative stress resulted from a low-fiber The mucosal barrier consists of mucosal layer, tight high-fat diet or a genotoxic carcinogen [18-20]. In junction and microflora, which protects the body addition, a previous study indicated that either from potential pathogens [4]. The tight junctions form KGM or inulin oligosaccharide could effectively the continuous intercellular barrier between the in- strengthen the colonic mucosal barrier and increase testinal epithelial cells is required to separate tissue the expressions of tight junction proteins occludin (a spaces, regulate selective movement of solutes across transmembrane barrier protein) and zone occludin- the epithelium and maintain the mucosal barrier 1 (ZO-1) (a peripheral scaffolding protein) [18]. function [4]. The reduced expression of tight junction These fibers also modulate gut immunity by protein may lead to translocation of endotoxins and increasing the colonic gene expression of IL-10, an bacterial antigens and causes excessive inflammation anti-inflammatory cytokine [16]. However, effects of in the gut-associated lymphocyte tissue [4]. KGM and the combination of KGM and inulin The colonic mucosa is constantly challenged by oligosaccharide on prevention of ulcerative colitis the reactive oxidative substances produced from the have never been examined. microbiota and lumen contents [5]. An imbalanced Dextran sodium sulfate (DSS) causes colonic in- cellular redox system of mucosa results excess testinal epithelial cell injury and has been used to reactive oxidative substance levels and subse- induce experimental colitis [21,22]. The present quently causes gastrointestinal tract inflammation study was undertaken to investigate effects of KGM, [5,6]. In addition, activated leukocytes during the inulin oligosaccharide and their mixture on the active phase of inflammation generate reactive colonic inflammation, tight junction proteins, anti- oxidative reactions that further impairs the mucosal oxidative enzymes, fecal microbiota and short-chain barrier [7]. Therefore, oxidative stress is considered fatty acids in a DSS-induced colitis mouse model. In to play an important role in the mucosal damage in order to be applicable to humans, the level of fiber IBD [5]. For examples, previous studies indicated supplementation was only 2% w/w, which is increased peroxidative products in both the ulcera- equivalent to 10 g/d of normal human diet. tive colitis mouse model and IBD patients [8,9]. Current medical treatments for IBD include corti- Methods costeroids, antibiotics, 5-aminosalicylic acid, immu- nomodulator and biological therapies [10]. Animals Traditional therapy may cause side effects due to immune-suppression [11]. Therefore, the need for Male C57BL/6J mice were purchased at 5 weeks of complementary and alternative medicine approaches age from the National Laboratory Animal Breeding for prevention and treatment of IBD is increasing [12]. and Research Center (Taipei, Taiwan). Animals Konjac glucomannan (KGM) is a viscous soluble were housed in a solid-bottomed plastic cage with fiber isolated from the underground tuber of stainless wire bar lid and wood shavings for Amorphophallus konjac [13]. It is composed of b-1, 4- bedding in an animal holding room maintained on a linked D-glucose and D-mannose units joined 12-h light/dark cycle at 24 ± 1C and 50 ± 2% hu- together with branches through b-1,6-glucosyl units midity. All animals were allowed free access to [13]. The KGM has been processed into various water and food in the present study. The care and vegetarian food products commonly consumed in use of animals was in accordance with European the Asian countries. Inulin, found in the under- Commission Directive 86/609/EEC for animal ground tuber of chicory (Cichorium intybus), is an experiment [23] and the guidelines of the National oligomer or polymer of b-D-fructose containing two Research Council [24]. All experimental procedures to mostly sixty monomeric units that are linked by involving animals were approved by the Institu- b-(2 / 1) glycosidic bridges [14]. The fraction of tional Animal Care and Use Committee. inulin with the degree of polymerization lower than 10, namely, inulin oligosaccharide, is widely used as Experimental
Load more

Recommended publications
  • Effect of Intake of Food Hydrocolloids of Bacterial Origin on the Glycemic Response in Humans: Systematic Review and Narrative Synthesis
    nutrients Review Effect of Intake of Food Hydrocolloids of Bacterial Origin on the Glycemic Response in Humans: Systematic Review and Narrative Synthesis Norah A. Alshammari 1,2, Moira A. Taylor 3, Rebecca Stevenson 4 , Ourania Gouseti 5, Jaber Alyami 6 , Syahrizal Muttakin 7,8, Serafim Bakalis 5, Alison Lovegrove 9, Guruprasad P. Aithal 2 and Luca Marciani 2,* 1 Department of Clinical Nutrition, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia; [email protected] 2 Translational Medical Sciences and National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK; [email protected] 3 Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen’s Medical Centre, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham NG7 2UH, UK; [email protected] 4 Precision Imaging Beacon, University of Nottingham, Nottingham NG7 2UH, UK; [email protected] 5 Department of Food Science, University of Copenhagen, DK-1958 Copenhagen, Denmark; [email protected] (O.G.); [email protected] (S.B.) 6 Department of Diagnostic Radiology, Faculty of Applied Medical Science, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia; [email protected] 7 Indonesian Agency for Agricultural Research and Development, Jakarta 12540, Indonesia; Citation: Alshammari, N.A.; [email protected] Taylor, M.A.; Stevenson, R.; 8 School of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK Gouseti, O.; Alyami, J.; Muttakin, S.; 9 Rothamsted Research, Harpenden, Hertfordshire AL5 2JQ, UK; [email protected] Bakalis, S.; Lovegrove, A.; Aithal, G.P.; * Correspondence: [email protected]; Tel.: +44-115-823-1248 Marciani, L.
    [Show full text]
  • Differential Effects of the Poly (ADP-Ribose)Polymerase (PARP
    British Journal of Cancer (2001) 84(1), 106–112 © 2001 Cancer Research Campaign doi: 10.1054/ bjoc.2000.1555, available online at http://www.idealibrary.com on http://www.bjcancer.com Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro KJ Bowman*, DR Newell, AH Calvert and NJ Curtin Cancer Research Unit, University of Newcastle upon Tyne Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK Summary The potent novel poly(ADP-ribose) polymerase (PARP) inhibitor, NU1025, enhances the cytotoxicity of DNA-methylating agents and ionizing radiation by inhibiting DNA repair. We report here an investigation of the role of PARP in the cellular responses to inhibitors of topoisomerase I and II using NU1025. The cytotoxicity of the topoisomerase I inhibitor, camptothecin, was increased 2.6-fold in L1210 cells by co-incubation with NU1025. Camptothecin-induced DNA strand breaks were also increased 2.5-fold by NU1025 and exposure to camptothecin-activated PARP. In contrast, NU1025 did not increase the DNA strand breakage or cytotoxicity caused by the topoisomerase II inhibitor etoposide. Exposure to etoposide did not activate PARP even at concentrations that caused significant levels of apoptosis. Taken together, these data suggest that potentiation of camptothecin cytotoxicity by NU1025 is a direct result of increased DNA strand breakage, and that activation of PARP by camptothecin-induced DNA damage contributes to its repair and consequently cell survival. However, in L1210 cells at least, it would appear that PARP is not involved in the cellular response to etoposide-mediated DNA damage.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0028333 A1 Piatesi Et Al
    US 20120028333A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0028333 A1 Piatesi et al. (43) Pub. Date: Feb. 2, 2012 (54) USE OF ENZYMES TO REDUCE ALDEHYDES (30) Foreign Application Priority Data FROMALDEHYDE-CONTAINING PRODUCTS Apr. 7, 2009 (EP) .................................. O9157522.5 Publication Classification (76) Inventors: Andrea Piatesi, Mannheim (DE); (51) Int. Cl. Tilo Habicher, Speyer (DE); CI2N 9/02 (2006.01) Michael Bischel, Worms (DE); CI2N I/00 (2006.01) Li-Wen Wang, Mannheim (DE): CI2N 15/63 (2006.01) Jirgen Reichert, Limburgerhof A62D 3/02 (2007.01) (DE); Rainer Packe-Wirth, C7H 2L/04 (2006.01) Trostberg (DE); Kai-Uwe (52) U.S. Cl. ... 435/189: 435/262:536/23.2:435/320.1; Baldenius, Heidelberg (DE); Erich 435/243 Kromm, Weisenheim am Sand (57) ABSTRACT (DE); Stefan Häfner, Speyer (DE); Carsten Schwalb. Mannheim (DE); The invention relates to the use of an enzyme preparation Hans Wolfgang Höffken, which catalyzes the degradation of formaldehyde for reduc Ludwigshafen (DE) ing the formaldehyde content in a formaldehyde-containing formulation. In a preferred embodiment, the enzyme prepa ration contains a formaldehyde dismutase from a Pseudomo (21) Appl. No.: 13/262,662 nas putida Strain. Further, the invention refers to a process for reducing the formaldehyde content in cross-linking agents for textile finishing or in polymer dispersions used, e.g. in con (22) PCT Filed: Mar. 31, 2010 struction chemistry. Further the invention relates to the use of an enzyme preparation which catalyzes the degradation of (86). PCT No.: PCT/EP1OAS4284 aldehydes for reducing the formaldehyde content in an alde hyde-containing formulation.
    [Show full text]
  • Selection of Cryoprotectant in Lyophilization of Progesterone-Loaded Stearic Acid Solid Lipid Nanoparticles
    pharmaceutics Article Selection of Cryoprotectant in Lyophilization of Progesterone-Loaded Stearic Acid Solid Lipid Nanoparticles Timothy M. Amis, Jwala Renukuntla, Pradeep Kumar Bolla and Bradley A. Clark * Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27268, USA; [email protected] (T.M.A.); [email protected] (J.R.); [email protected] (P.K.B.) * Correspondence: [email protected]; Tel.: +1-336-841-9665 Received: 18 August 2020; Accepted: 16 September 2020; Published: 19 September 2020 Abstract: Cryoprotectants are often required in lyophilization to reduce or eliminate agglomeration of solute or suspended materials. The aim of this study was to select a cryoprotecting agent and optimize its concentration in a solid lipid nanoparticle formulation. Progesterone-loaded stearic acid solid lipid nanoparticles (SA-P SLNs) were prepared by hot homogenization with high speed mixing and sonication. The stearic acid content was 4.6% w/w and progesterone was 0.46% w/w of the initial formulation. Multiple surfactants were evaluated, and a lecithin and sodium taurocholate system was chosen. Three concentrations of surfactant were then evaluated, and a concentration of 2% w/w was chosen based on particle size, polydispersity, and zeta potential. Agglomeration of SA-P SLNs after lyophilization was observed as measured by increased particle size. Dextran, glycine, mannitol, polyvinylpyrrolidone (PVP), sorbitol, and trehalose were evaluated as cryoprotectants by both an initial freeze–thaw analysis and after lyophilization. Once selected as the cryoprotectant, trehalose was evaluated at 5%, 10%, 15%, and 20% for optimal concentration, with 20% trehalose being finally selected as the level of choice.
    [Show full text]
  • 6) Dextran Antibody → Behavior of an Anti
    Position Effects of Variable Region Carbohydrate on the Affinity and In Vivo Behavior of an Anti-(1→6) Dextran Antibody This information is current as M. Josefina Coloma, Ryan K. Trinh, Alexander R. Martinez of September 27, 2021. and Sherie L. Morrison J Immunol 1999; 162:2162-2170; ; http://www.jimmunol.org/content/162/4/2162 Downloaded from References This article cites 45 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/162/4/2162.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1999 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Position Effects of Variable Region Carbohydrate on the Affinity and In Vivo Behavior of an Anti-(136) Dextran Antibody1 M. Josefina Coloma, Ryan K. Trinh, Alexander R. Martinez, and Sherie L. Morrison2 IgG is a glycoprotein with an N-linked carbohydrate structure attached to the CH2 domain of each of its heavy chains.
    [Show full text]
  • Physical Charaterization of Red Blood Cell Aggregation Daniel Amadeus Dominic Flormann
    Physical charaterization of red blood cell aggregation Daniel Amadeus Dominic Flormann To cite this version: Daniel Amadeus Dominic Flormann. Physical charaterization of red blood cell aggregation. Biological Physics [physics.bio-ph]. Universität des Saarlandes, 2017. English. NNT : 2017GREAY002. tel- 01577838 HAL Id: tel-01577838 https://tel.archives-ouvertes.fr/tel-01577838 Submitted on 28 Aug 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Pour obtenir le grade de DOCTEUR DE LA COMMUNAUTÉ UNIVERSITÉ GRENOBLE ALPES préparée dans le cadre d’une cotutelle entre la Communauté Université Grenoble Alpes et l’Universität des Saarlandes Spécialité : Physique pour les sciences du vivant Arrêté ministériel : 25 mai 2016 Présentée par Daniel Amadeus Dominic Flormann Thèse dirigée par M. Thomas Podgorski et M. Christian Wagner préparée au sein du Laboratoire Interdisciplinaire de Physique, Grenoble et de Experimentalphysik, Saarbrücken dans les Écoles doctorales de Physique de l’Université Grenoble Alpes et de Dekanat der Universität des Saarlandes
    [Show full text]
  • Red Blood Cell Aggregation in Preterm and Term Neonates and Adults
    1356 LINDERKAMP ET AL. 003 1-3998/84/18 12-1356$02.00/0 PEDIATRIC RESEARCH Vol. 18, No. 12, 1984 Copyright O 1984 International Pediatric Research Foundation, Inc. Printed in U.S. A. Red Blood Cell Aggregation in Preterm and Term Neonates and Adults OTWIN LINDERKAMP, PATRICK OZANNE, PAUL Y. K. WU, AND HERBERT J. MEISELMAN Department of Pediatrics, University of Heidelberg, Federal Republic of Germany and Department of Physiology and Biophysics and Department of Pediatrics, University of Southern California, Los Angeles, California 90024 ABSTRACT. Aggregation of red blood cells (RBC) is a only during stasis or at low shear stresses (5, 22, 23). ~t high major determinant of blood viscosity and of blood circula- shear stresses (about 3 dynes/cm2 or more), RBC aggregates are tion through vessels with slow flow (i.e. veins). RBC ag- rapidly dispersed (23). Thus, RBC aggregation usually takes place gregation and plasma fibrinogen were studied in placental only in the venous portion of the circulation where the blood blood samples from 25 neonates with 24 to 41 wk of flow rate is slow and the fluid shear stresses are low. RBC gestation and in blood from 13 normal adults. The rate and aggregation may occur in other sections of the circulation, how- final extent of RBC aggregation were measured by means ever, under pathophysiological situations of reduced blood flow of a rheoscope (increase in light transmission during blood (i.e. shock). Conversely, increased RBC aggregation (e.g. as a stasis). Both the rate and extent of RBC aggregation were result of high fibrinogen level) can cause lower blood flow rates, low in the premature infants, increased with gestational and this latter mechanism has been suggested as a possible factor age, and reached the highest values in the adults.
    [Show full text]
  • UHPLC Analysis of 2-AB-Labeled Dextran Ladder and Assignment of Glucose Units to Unknown Glycans
    Technical Note 147 Note Technical UHPLC Analysis of 2-AB-labeled Dextran Ladder and Assignment of Glucose Units to Unknown Glycans Mauro De Pra,1 Barbara van Cann,1 and Peter Sauter2 1Thermo Fisher Scientific, Amsterdam, The Netherlands;2 Thermo Fisher Scientific, Germering, Germany Key Words Chromeleon 7.2 CDS, HILIC, Biomolecules, Dextran, UltiMate 3000 BioRS, Accucore Introduction Analysis of glycans labeled with 2-aminobenzamide (2-AB) by hydrophilic interaction liquid chromatography (HILIC) is a common and effective technique used in the field of glycomics and bio-pharmaceutical analysis. HILIC separation of 2-AB-glycans is usually accomplished with amide-bonded stationary phases and the labeled glycans can be detected by fluorescence with excellent sensitivity. The labeling occurs at the reducing end of the oligosac- charide, which ensures each glycan will react with only one 2-AB molecule, making this approach also suitable for quantitative analysis. In any workflow that relies on GU measurement, high The hydrophilicity of a 2-AB glycan increases with the retention time precision is mandatory in order to obtain a molecular weight, hence with the number of carbohydrate reliable calibration curve, and to correctly assign GU monomers. Because the main retention mechanism of values to the unknown glycans afterward. 2-AB-glycans with amide columns is hydrophilic interac- In this paper we propose a solution for assignment of GU tion, larger glycans will be more retained than smaller values to unknown glycans using HILIC separation and ones. A typical example is the retention of linear glucose fluorescence detection. The solution includes: oligomers, where the retention time increases with the number of monomeric units.
    [Show full text]
  • Dextran in Sugar Manufacture - Problem Evaluation and Enzyme-Based Mitigation
    DEXTRAN IN SUGAR MANUFACTURE - PROBLEM EVALUATION AND ENZYME-BASED MITIGATION vorgelegt von M.Sc. vorgelegt von M. Sc. Karin Abraham von der Fakultät III – Prozesswissenschaften, der Technischen Universität Berlin zur Erlangung des akademischen Grades Doktor der Ingenieurwissenschaften - Dr.-Ing. - genehmigte Dissertation Promotionsausschuss: Vorsitzende: Prof. Dr.-Ing. habil. Cornelia Rauh Gutachter: Dr. Jan Maarten de Bruijn Gutachter: Prof. Dr.-Ing. Eckhard Flöter Gutachter: Dr. Lutz Popper Tag der wissenschaftlichen Aussprache: 20. Juni 2019 Berlin 2019 ABSTRACT It is well-known that the presence of the microbial polysaccharide dextran in sugar beet and cane juices can affect sugar manufacture in many ways. However, a controlled mitigation of dextran- induced effects during sugar processing by enzymatic decomposition is still not established practice, which is what this work is aiming at. The first step towards this is the detailed understanding of the effects of dextran as well as of enzymatically decomposed dextran during sugar manufacture. Therefore, laboratory juice purification and crystallisation experiments with synthetic thin and thick juices containing various dextran contents of different molecular masses were performed. This also includes enzymatic decompositions of dextran using various enzyme levels. Thereby, the most harmless reaction products with regard to these two process steps were identified. For the purification process by means of lime and carbonation gas, it was shown that dextran is involved in size and shape modifications of calcium carbonate particles precipitated during carbonation. This could affect both, the filtration as well as the purification performance. The data indicate that the presence of dextran with molecular masses above 10 kDa promotes calcium carbonate agglomeration.
    [Show full text]
  • Safety Assessment of Microbial Polysaccharide Gums As Used in Cosmetics
    Safety Assessment of Microbial Polysaccharide Gums as Used in Cosmetics Status: Final Report for public distribution Release Date: October 5, 2012 Panel Meeting Date: September 10-11, 2012 The 2012 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D., Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is F. Alan Andersen, Ph.D. This report was prepared by Monice M. Fiume, Senior Scientific Analyst/Writer, and Bart A. Heldreth, Ph.D., Chemist, CIR. Cosmetic Ingredient Review 1101 17th Street, NW, Suite 412 ♢ Washington, DC 20036-4702 ♢ ph 202.331.0651 ♢ fax 202.331.0088 ♢ [email protected] ABSTRACT The CIR Expert Panel assessed the safety of 34 microbial polysaccharide gums for use in cosmetics, finding that these ingredients are safe in cosmetic formulations in the present practices of use and concentration. The microbial polysaccharide gums named in this report have a variety of reported functions in cosmetics, including emulsion stabilizer, film former, binder, viscosity increasing agent, and skin conditioning agent. The Panel reviewed available animal and clinical data in making its determination of safety. INTRODUCTION This assessment is a review of information relevant to the safety of 34 microbial polysaccharide gums for use in cosmetic formula- tions. Reported functions for these ingredients include emulsion stabilizer, film former, binder, viscosity increasing agent, and skin conditioning agent.
    [Show full text]
  • Charge-Dependent Targeting: Results in Six Tumor Cell Lines
    ANTICANCER RESEARCH 24: 1347-1352 (2004) Charge-dependent Targeting: Results in Six Tumor Cell Lines MARCELA MÁRQUEZ1, STEN NILSSON1, LENA LENNARTSSON1, ZHAOXU LIU1,4, TEUVO TAMMELA2, MIKA RAITANEN3 and ANDERS R. HOLMBERG1 1Karolinska Institute, Cancer Center Karolinska, S-17176 Stockholm, Sweden; 2Tampere University Hospital, Division of Urology, FIN-33521 Tampere, Finland; 3Seinäjoki Central Hospital, 60220 Seinäjoki, Finland; 4School of Nursing Shandong University, 250012 Jinan, China Abstract. Background: Many previous studies show that acid residues and causes fatal disturbances in the cell cell surface sialylation of malignant cells is enhanced membrane. However the exact mechanism remains to be compared to normal tissue. The carboxyl group of the sialic elucidated. The results may indicate a new method of acid yields a negative surface charge of the tumor cells. This general interest for intra/local/regiolocal treatment of study investigates how tumor cell growth is affected when a cancer. Clinical studies to explore this concept are pending. cationic polymer is incubated with six different tumor cell In an earlier study it was demonstrated that intravesical lines. Materials and Methods: Cationic dextran (CatDex) instillation of a polymer with cationic charge resulted in was prepared by periodate oxidation and subsequent selective accumulation in the tumor tissue in patients coupling of cationic sidegroups by reductive amination. A with superficial bladder cancer. The effect was fluorimetric cytotoxicity assay (FMCA) was used for the cell pronounced and dependent on the cationic charge of the survival assay. Six different tumor cell lines (lung, breast, polymer. High ratios between normal and tumor tissue ovarian, prostate, colon, urinary bladder) were seeded into were observed (1).
    [Show full text]
  • Glycation of Plant Proteins Via Maillard Reaction: Reaction Chemistry, Technofunctional Properties, and Potential Food Application
    foods Review Glycation of Plant Proteins Via Maillard Reaction: Reaction Chemistry, Technofunctional Properties, and Potential Food Application Ines Kutzli 1,2 , Jochen Weiss 1 and Monika Gibis 1,* 1 Department of Food Material Science, Institute of Food Science and Biotechnology, University of Hohenheim, Garbenstrasse 21/25, 70599 Stuttgart, Germany; [email protected] (I.K.); [email protected] (J.W.) 2 Food and Soft Materials, Institute of Food, Nutrition and Health, ETH Zurich, Schmelzbergstrasse 9, 8092 Zurich, Switzerland * Correspondence: [email protected] Abstract: Plant proteins are being considered to become the most important protein source of the future, and to do so, they must be able to replace the animal-derived proteins currently in use as techno-functional food ingredients. This poses challenges because plant proteins are oftentimes storage proteins with a high molecular weight and low water solubility. One promising approach to overcome these limitations is the glycation of plant proteins. The covalent bonding between the proteins and different carbohydrates created via the initial stage of the Maillard reaction can improve the techno-functional characteristics of these proteins without the involvement of potentially toxic chemicals. However, compared to studies with animal-derived proteins, glycation studies on plant proteins are currently still underrepresented in literature. This review provides an overview of the existing studies on the glycation of the major groups of plant proteins with different carbohydrates Citation: Kutzli, I.; Weiss, J.; Gibis, using different preparation methods. Emphasis is put on the reaction conditions used for glycation M. Glycation of Plant Proteins Via as well as the modifications to physicochemical properties and techno-functionality.
    [Show full text]